Voxelwise evaluation of white matter volumes in first-episode psychosis

Imagem de Miniatura
Arquivos
art_COLOMBO_Voxelwise_evaluation_of_white_matter_volumes_in_first_2012.PDF (269.04 KB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2012
Editora
ELSEVIER IRELAND LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PSYCHIATRY RESEARCH-NEUROIMAGING, v.202, n.3, p.198-205, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The occurrence of white matter (WM) abnormalities in psychotic disorders has been suggested by several studies investigating brain pathology and diffusion tensor measures, but evidence assessing regional WM morphometry is still scarce and conflicting. In the present study, 122 individuals with first-episode psychosis (FEP) (62 fulfilling criteria for schizophrenia/schizophreniform disorder, 26 psychotic bipolar I disorder, and 20 psychotic major depressive disorder) underwent magnetic resonance imaging, as well as 94 epidemiologically recruited controls. Images were processed with the Statistical Parametric Mapping (SPM2) package, and voxel-based morphometry was used to compare groups (t-test) and subgroups (ANOVA). Initially, no regional WM abnormalities were observed when both groups (overall FEP group versus controls) and subgroups (i.e., schizophrenia/schizophreniform, psychotic bipolar I disorder, psychotic depression, and controls) were compared. However, when the voxelwise analyses were repeated excluding subjects with comorbid substance abuse or dependence, the resulting statistical maps revealed a focal volumetric reduction in right frontal WM, corresponding to the right middle frontal gyral WM/third subcomponent of the superior longitudinal fasciculus, in subjects with schizophrenia/schizophreniform disorder (n = 40) relative to controls (n = 89). Our results suggest that schizophrenia/schizophreniform disorder is associated with right frontal WM volume decrease at an early course of the illness.
Palavras-chave
White matter, Psychosis, Schizophrenia, Depression, Magnetic resonance imaging
URI
https://observatorio.fm.usp.br/handle/OPI/686
Referências
  1. American Psychiatric Association, 1994, DIAGN STAT MAN MENT
  2. Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006
  3. Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005
  4. BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11
  5. Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020
  6. Bruno SD, 2004, BRAIN, V127, P2433, DOI 10.1093/brain/awh274
  7. Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691
  8. Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009
  9. Cocchi L, 2009, SCHIZOPHR RES, V115, P163, DOI 10.1016/j.schres.2009.09.009
  10. Demirakca T, 2011, ALCOHOL CLIN EXP RES, V35, P1678, DOI 10.1111/j.1530-0277.2011.01514.x
  11. Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021
  12. Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812
  13. Firbank MJ, 2003, NEUROLOGY, V61, P950
  14. First M.B., 1995, STRUCTURED CLIN INTE
  15. Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
  16. Hanlon CA, 2011, PSYCHOPHARMACOLOGY, V218, P681, DOI 10.1007/s00213-011-2360-y
  17. Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199
  18. Pol HEH, 2006, NEUROIMAGE, V31, P482, DOI 10.1016/j.neuroimage.2005.12.056
  19. James A, 2011, SCHIZOPHR RES, V128, P91, DOI 10.1016/j.schres.2011.02.014
  20. Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017
  21. Karlsgodt KH, 2009, BIOL PSYCHIAT, V66, P562, DOI 10.1016/j.biopsych.2009.03.013
  22. Korgaonkar M.S., 2011, HUMAN BRAIN MAPPING, V32, P2161
  23. Lee W, 2007, BRIT J PSYCHIAT, V190, P204, DOI 10.1192/bjp.bp.106.027250
  24. Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823
  25. McDonald C, 2004, ARCH GEN PSYCHIAT, V61, P974, DOI 10.1001/archpsyc.61.10.974
  26. McDonald C, 2005, BRIT J PSYCHIAT, V186, P369, DOI 10.1192/bjp.186.5.369
  27. McIntosh AM, 2005, BIOL PSYCHIAT, V58, P254, DOI 10.1016/j.biopsych.2005.03.044
  28. Menezes P.R., 2007, BRIT J PSYCHIAT S, V51, P102
  29. Mitelman SA, 2007, SCHIZOPHR RES, V92, P211, DOI 10.1016/j.schres.2006.12.029
  30. Moriya J, 2010, SCHIZOPHR RES, V116, P196, DOI 10.1016/j.schres.2009.10.002
  31. Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029
  32. Oishi S., 2011, MRI ATLAS HUMAN WHIT
  33. Pell GS, 2008, NEUROIMAGE, V41, P1324, DOI 10.1016/j.neuroimage.2008.02.050
  34. Perico CD, 2011, BIPOLAR DISORD, V13, P28, DOI 10.1111/j.1399-5618.2011.00896.x
  35. Plaze M, 2011, SCHIZOPHRENIA BULL, V37, P212, DOI 10.1093/schbul/sbp081
  36. Pol HEH, 2004, BIOL PSYCHIAT, V55, P126, DOI 10.1016/S0006-3223(03)00728-5
  37. Price G, 2010, NEUROIMAGE, V49, P185, DOI 10.1016/j.neuroimage.2009.07.037
  38. Rowland LM, 2009, NEUROPSYCHOPHARMACOL, V34, P1514, DOI 10.1038/npp.2008.207
  39. Schaufelberger M.S., 2007, BR J PSYCHIAT S51, V191, P117
  40. Scherk H, 2008, EUR ARCH PSY CLIN N, V258, P345, DOI 10.1007/s00406-007-0801-8
  41. Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017
  42. Shapleske J, 2002, CEREB CORTEX, V12, P1331, DOI 10.1093/cercor/12.12.1331
  43. Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3
  44. Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480
  45. Talairach J.P., 1988, COPLANAR STEREOTACTI
  46. Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030
  47. Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008
  48. Tost H, 2010, J AFFECT DISORDERS, V120, P54, DOI 10.1016/j.jad.2009.04.009
  49. van der Schot AC, 2009, ARCH GEN PSYCHIAT, V66, P142, DOI 10.1001/archgenpsychiatry.2008.541
  50. Vederine FE, 2011, PROG NEURO-PSYCHOPH, V35, P1820, DOI 10.1016/j.pnpbp.2011.05.009
  51. Wacholder S, 1995, Stat Methods Med Res, V4, P293, DOI 10.1177/096228029500400403
  52. Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001
  53. Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082
  54. Witthaus H, 2008, SCHIZOPHR RES, V102, P141, DOI 10.1016/j.schres.2008.03.022
  55. Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002
  56. Xu L, 2009, NEUROIMAGE, V44, P777, DOI 10.1016/j.neuroimage.2008.09.051
  57. Zanetti MV, 2009, EUR ARCH PSY CLIN N, V259, P316, DOI 10.1007/s00406-009-0002-8
  58. Zanetti MV, 2008, BRIT J PSYCHIAT, V193, P25, DOI 10.1192/bjp.bp.107.038901

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - LIM/39